Moreover, multiple reversion events in BRCA1/2 genes have been reported as a mechanism of platinum-resistance in a study of whole-genome characterization of chemo-resistant ovarian cancer [27]. This evidence concerns the gene BRCA1 and ovarian carcinoma.